Phase I clinical data on novel anticancer, antiangiogenesis drug.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012509:Sarcoma / Q000188:drug therapy*; D014970:Xanthines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D014970:Xanthines; C106011:CT 2584